Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -0.19% is 99% above its 5-year average of -16.98%, near the high end of its 5-year range (-70.95%–7.92%).
94.72% above its 12-month average of -3.60%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -10.77%.
EBITDA MARGIN
-0.19%
EBITDA MARGIN AVG TTM
-3.60%
EBITDA MARGIN AVG 3Y
-3.48%
EBITDA MARGIN AVG 5Y
-16.98%
EBITDA MARGIN AVG 10Y
-18.38%
EBITDA MARGIN AVG 15Y
-25.32%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+94.72%
CURRENT VS 3Y AVG
+94.53%
CURRENT VS 5Y AVG
+98.88%
CURRENT VS 10Y AVG
+98.97%
CURRENT VS 15Y AVG
+99.25%
CURRENT VS 20Y AVG
N/A
Market Cap
$136.51M
EBITDA Margin
-5.26%
TTM Avg
-11.06%
3Y Avg
-22.91%
5Y Avg
-20.50%
Market Cap
$137.77M
EBITDA Margin
-103.63%
TTM Avg
-143.63%
3Y Avg
-176.25%
5Y Avg
-194.05%
Market Cap
$139.33M
EBITDA Margin
5.24%
TTM Avg
5.41%
3Y Avg
5.74%
5Y Avg
10.79%
Market Cap
$138.69M
EBITDA Margin
-221.15%
TTM Avg
-221.15%
3Y Avg
-221.15%
5Y Avg
-221.15%
Market Cap
$129.68M
EBITDA Margin
4.63%
TTM Avg
-2.31%
3Y Avg
-16.32%
5Y Avg
-24.77%
Market Cap
$140.10M
EBITDA Margin
-783.01%
TTM Avg
-1033.45%
3Y Avg
-1010.27%
5Y Avg
-3715.70%
Market Cap
$143.39M
EBITDA Margin
-16238.30%
TTM Avg
-8929.91%
3Y Avg
-4730.54%
5Y Avg
-4730.54%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMD) | $134.69M | -0.19% | -3.60% | -3.48% | -16.98% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.51M | -5.26% | -11.06% | -22.91% | -20.50% |
| Freenome, Inc. (FRNM)vs › | $132.31M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $137.77M | -103.63% | -143.63% | -176.25% | -194.05% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $139.33M | 5.24% | 5.41% | 5.74% | 10.79% |
| Alpha Cognition Inc (ACOG)vs › | $138.69M | -221.15% | -221.15% | -221.15% | -221.15% |
| Health Catalyst, Inc. (HCAT)vs › | $129.68M | 4.63% | -2.31% | -16.32% | -24.77% |
| Nyxoah S.A. (NYXH)vs › | $140.10M | -783.01% | -1033.45% | -1010.27% | -3715.70% |
| Immuneering Corporation (IMRX)vs › | $143.39M | -16238.30% | -8929.91% | -4730.54% | -4730.54% |
| Entera Bio Ltd. (ENTX)vs › | $126.43M | -27378.57% | -16324.37% | -14117.74% | -9505.20% |
Gross Margin
85.9%
EBITDA Margin
-0.2%
Operating Margin
-9.3%
Net Margin
-10.4%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -10.77% |
| 2026-03-31 | -13.82% |
| 2025-12-31 | 1.82% |
| 2025-09-30 | 1.70% |
| 2025-06-30 | 3.08% |
| 2025-03-31 | 7.92% |
| 2024-12-31 | 5.55% |
| 2024-09-30 | -2.70% |
| 2024-06-30 | -7.93% |
| 2024-03-31 | -9.22% |
| 2023-12-31 | -4.16% |
| 2023-09-30 | -7.34% |
| 2023-06-30 | -9.29% |
| 2023-03-31 | -4.48% |
| 2022-12-31 | -35.80% |
| 2022-09-30 | -18.86% |
| 2022-06-30 | -39.54% |
| 2022-03-31 | -43.30% |
| 2021-12-31 | -48.56% |
| 2021-09-30 | -50.00% |
| 2021-06-30 | -70.95% |
| 2021-03-31 | -64.90% |
| 2020-12-31 | -249.88% |
| 2020-09-30 | -185.58% |
| 2020-06-30 | -34.38% |
| 2020-03-31 | -38.42% |
| 2019-12-31 | -11.04% |
| 2019-09-30 | -28.46% |
| 2019-06-30 | -27.77% |
| 2019-03-31 | -17.76% |
| 2018-12-31 | -26.86% |
| 2018-09-30 | -16.32% |
| 2018-06-30 | -29.07% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 10.93% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 13.98% |
| 2017-03-31 | 6.32% |
| 2016-12-31 | -70.73% |
| 2016-09-30 | -14.21% |
| 2016-06-30 | -11.63% |
| 2016-03-31 | -5.74% |
| 2015-12-31 | -72.54% |
| 2015-09-30 | 11.86% |
| 2015-06-30 | -1.05% |
| 2015-03-31 | 7.66% |
| 2014-12-31 | -81.85% |
| 2014-09-30 | -71.74% |
| 2014-06-30 | -31.09% |
| 2014-03-31 | -84.91% |
| 2013-12-31 | -169.79% |
| 2013-09-30 | -163.11% |
| 2013-06-30 | -1.83% |
| 2013-03-31 | -24.56% |
| 2012-12-31 | -95.47% |
| 2012-09-30 | -98.31% |
| 2012-06-30 | -88.53% |
| 2012-03-31 | -12.17% |
